ClinicalTrials.Veeva

Menu

Project PROTECT: Protecting Nursing Homes From Infections and Hospitalization

University of California Irvine (UCI) logo

University of California Irvine (UCI)

Status and phase

Completed
Phase 4

Conditions

Infection
Hospitalization

Treatments

Drug: Chlorhexidine gluconate (CHG)
Drug: Iodophor (10% povidone-iodine)

Study type

Interventional

Funder types

Other
Other U.S. Federal agency

Identifiers

NCT03118232
20151805

Details and patient eligibility

About

This is a cluster-randomized trial of nursing homes to assess whether decolonization with routine chlorhexidine bathing and periodic use of nasal antiseptics can reduce hospitalizations associated with infections, antibiotic utilization, and multi-drug resistant organism (MDRO) prevalence. The comparator arm will be routine bathing care.

Enrollment

13,952 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

Nursing homes will be eligible to participate if they meet the following criteria:

  • Licensed nursing home in Orange County or Southern Los Angeles County serving adults
  • Minimal use of chlorhexidine bathing*
  • Minimal use of nasal decolonization* *Minimal use defined as <15% of residents receiving at least one chlorhexidine bath or nasal decolonization treatment during their nursing home stay.

Exclusion Criteria

Nursing homes will not be eligible to participate if they meet the following criteria:

  • Facilities routinely using decolonization
  • Dedicated psychiatric nursing homes
  • Facilities with a resident population with >=20% combative patients
  • Pediatric facilities

Note: in any participating nursing home, residents with active end-of-life comfort care only measures are excluded

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

13,952 participants in 2 patient groups

Decolonization
Active Comparator group
Description:
Nursing homes assigned to this arm will perform decolonization using topical antiseptic products.
Treatment:
Drug: Chlorhexidine gluconate (CHG)
Drug: Iodophor (10% povidone-iodine)
Routine Bathing
No Intervention group
Description:
Routine bathing per facility protocol.

Trial documents
1

Trial contacts and locations

28

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems